shot-button
Olympic 2024 Olympic 2024
Home > Sports News > Cricket News > Article > Giles Shield Aryans patient 85 takes Anjuman to 216 for eight

Giles Shield: Aryan's patient 85 takes Anjuman to 216 for eight

Updated on: 14 January,2020 08:36 AM IST  |  Mumbai
A correspondent |

The second semi-final between defending champions Al Barkaat MMI (Kurla) and VN Sule Guruji Vidyalaya (Dadar) will be played at Oval Maidan from today

Giles Shield: Aryan's patient 85 takes Anjuman to 216 for eight

Anjuman-I-Islam's Aryan Deshmukh during his gritty 85 against SVIS (Borivli) at Parsee Gymkhana yesterday. Pic/Suresh Karkera

Aryan Deshmukh's fighting 180-ball 85 took Anjuman-I-Islam Allana (CST) to 216-8 against Swami Vivekanand International School (Borivli) on Day One of the two-day MSSA-organised U-14 Giles Shield first semi-final at Parsee Gymkhana on Monday.


Put in to bat, the CST school were reduced to 28-2 at the start with pacer SVIS Aayush Vaity claiming both wickets. Aryan, however, toiled hard and went on to share a 51-run partnership for the third wicket with Shlok Bhise.


He then put on 78 runs for the fourth wicket with Prithvi Gowari and another 24 for the fifth wicket with Kaif Ansari to bring his side back on track before being dismissed by spinner Arya Deshpande with the score reading 181-5.


Aayush claimed three wickets, while spinners Rudra Tank and Ishan Parab claimed two wickets each for SVIS.

The second semi-final between defending champions Al Barkaat MMI (Kurla) and VN Sule Guruji Vidyalaya (Dadar) will be played at Oval Maidan from today.

Catch up on all the latest sports news and updates here. Also download the new mid-day Android and iOS apps to get latest updates

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK